. The high basal level of prolactin PRL gene expression in rat pituitary GH cells is maintained through the spontaneous 3 Ž . activity of voltage-sensitive calcium channels VSCCs . This can be observed experimentally by addition of 0.5 mM CaCl 2 to GH cells cultured in a low calcium, serum-free medium. CaCl specifically induces PRL gene expression and this 3 2 3 with herbimycin A, bFGF induced a reappearance of tyrosine-specific phosphorylation, followed by a reappearance of PRL mRNA. These findings provide evidence for a role for at least one PTK which is necessary for basal and stimulated PRL gene expression. q 1997 Elsevier Science B.V.
induction is inhibited by VSCC blockers. PRL gene expression is also stimulated by several hormones and growth factors. In the present study, we examined the effects of tyrosine kinase inhibitors on the ability of CaCl , basic fibroblast growth 2 Ž . Ž . Ž . factor bFGF , epidermal growth factor EGF and thryrotropin-releasing hormone TRH to increase PRL mRNA levels. Of several PTK inhibitors used, one PTK inhibitor, herbimycin A, specifically inhibited the CaCl -induced increase in 2 
Ž
. cytoplasmic and nuclear prolactin PRL mRNA without affecting cell viability, cell-cell and cell-matrix adhesion, or the expression of several other genes. The effects of herbimycin A were reversible. In cells pretreated with herbimycin A, PRL Ž . mRNA levels were reduced by 69 " 12% P -0.001; n s 4 .Western blot analysis using anti-phosphotyrosine antibody Ž . revealed a decrease of 91 " 1% P -0.001; n s 4 in the phosphotyrosine content of proteins in the molecular weight range of 130-160 kDa. After changing the medium back to SFM plus 0.5 mM CaCl , levels of PRL mRNA increased over 2 a period of several hours, and this increase was accompanied by the tyrosine phosphorylation of two or more proteins in the approximate size range of 130-160 kDa. Herbimycin A also inhibited PRL gene expression in the independently-derived Ž . 235-1 lactotrope cell line and lowered the tyrosine specific phosphorylation of protein s in a similar size range. Herbimycin A inhibited the ability of bFGF, EGF and TRH to stimulate PRL gene expression in GH cells. Again, in cells pretreated
Introduction
Extracellular CaCl can maintain a high basal . type voltage-sensitive Ca channels VSCCs and w x calmodulin in this response 4-7 , whereas protein w x kinase C does not appear to be involved 8,9 . Studies on other cell types have established a Ž . relationship between protein tyrosine kinases PTKs and the regulation by extracellular CaCl of a cellular 2 response. For example, the induction of mouse keratinocyte differentiation by calcium requires activation of the nonreceptor PTK, fyn, and at least one other w x PTK 10 . In neuronal PC12 cells, the VSCC agonist, BAY K8644, activates MAP kinase via a Ras-depenw x dent pathway 11 . The present study was undertaken to investigate whether PTKs were required for the maintenance of PRL gene expression by extracellular CaCl in two independently-derived pituitary tumor 2 cell lines. We report here that the PTK inhibitor, herbimycin A, specifically and reversibly represses CaCl -supported PRL gene expression in GH3 and 2 235-1 cells. Herbimycin A also specifically blocked the ability of bFGF, EGF and TRH to increase PRL gene expression. These studies provide evidence for at least one PTK which is necessary for basal and stimulated PRL gene expression.
Materials and methods
The cloned probes for PRL, GH, and glucose-regu-Ž . lated protein 78 GRP78 were described previously w x 2,3 . cally lower intracellular Ca 2q , but does allow one to observe the effects of the VSCC on PRL gene expression by adding 0.5 mM CaCl . GH cells cul- 2 3 tured in SFM show greater than 90% viability for several days, and respond to stimulators of either w x PRL or GH gene expression 2,13 . The exact treatment for each experiment is described in the legend to the corresponding figure. Herbimycin A, lavendustin A, and methyl-2,5 dihyroxycinnamate were Ž purchased from Life Technologies Gaithersburg, . MD , and were diluted in PBS from a DMSO stock solution. Genistein, daidzein, and RG-13022 were Ž . obtained from BIOMOL Plymouth Meeting, PA . Basic FGF, EGF and TRH were obtained from Sigma Ž . St. Louis, MO .
Analysis of mRNA leÕels by Northern blot hybridization
Preparation of cytoplasmic mRNA for analysis by either Northern blot or RNA dot hybridization was w x performed as described 15 except that the spin step with vanadyl-ribonucleoside complexes was omitted. For the preparation of nuclear RNA, GH3 cells were collected, pooled, washed once in PBS, and then resuspended in 0.9 ml of PBS. Cells were lysed by addition of 0.5% NP40, incubated on ice for 3 min, then centrifuged at 1000 = g for 5 min at 48C. The nuclear RNA was isolated by guanidine extraction w x and centrifugation through CsCl 14 . The relative levels of specific mRNAs were measured by Northern blot hybridization using 1% agaroserformalw x dehyde gels as described 3 . Gels were stained prior to transfer with ethidium bromide in order to measure relative mobilities of 28 s and 18 s ribosomal RNAs, and to ascertain even loading. The DNA probes were labeled with 32 P-dCTP using the Nick-Translation Ž . Kit N5000 Amersham, Arlingtin Heights, IL or by Ž the RTS RadPrime DNA labeling system Life Tech-. nologies, Gaithersburg, MD , followed by purifica-Ž tion using MicroSpin S-200 HR columns Pharmacia, . Piscataway, NJ .
Western blot analysis of phosphotyrosyl-containing proteins
For phosphotyrosine immunoblotting, samples were electrophoresed on either 8% or 10% SDS-polyacrylamide gels as indicated. For analysis of whole Ž cells, the medium was removed and the cells plated . at equal densities for each treatment were dissolved by scraping with a Teflon policeman in 250 ml of ( ) w x boiling Laemmli sample buffer 16 . The samples were then boiled for 5 min and the DNA was sheared by passing 5 times through a 26 gauge needle. Insoluble material was removed by centrifuging the cell lysates for 5 min in a microcentrifuge at 10 000 = g. Prior to electrophoresis, cell extracts were diluted and the protein concentration of each sample was deterw x mined 17 . Typically, 100 mg of protein was electrophoresed. Nitrocellulose sheets were blocked with Ž 10% bovine serum albumin BSA, Boehringer . Mannheim, Indianapolis, IN in Tris-buffered saline Ž . 100 mM NaCl, 50 mM Tris-HCl, pH 7.6 containing 0.1% Tween-20 overnight with agitation at room temperature. After removal of blocking solution, an-Ž tiphosphotyrosine antibody Upstate Biotechcnology, . Lake Placid, NY at a dilution of 1:1000 in TBS containing 3% BSA was added and the blots were incubated at room temperature with agitation for 1 to 2 h. Horseradish peroxidase conjugated sheep anti-Ž mouse antibody Kirkegaard and Perry, Inc., . Gaithersburg, MD was used at a dilution of 1:25 000 as a secondary antibody and reactivity was deter-Ž . mined by chemiluminescence Kirkegaard and Perry according to manufacturers instructions. 
Quantification of autoradiograms and statistical analysis

Results
Herbimycin A specifically blocked the ability of extracellular CaCl to maintain high PRL mRNA
2 leÕels in somatolactotrope GH cells 3 We first screened the effects of several PTK inhibitors on the ability of 0.5 mM CaCl to return 2 PRL gene expression to a high basal level in GH 3 cells cultured in SFM. The following inhibitors were examined: genistein, lavendustin A, erbstatin analogue, the tyrophostin RG-13022 and herbimycin A. Genistein and herbimycin A reduced PRL mRNA Ž . levels by approximately 80% Fig. 1 . Lavendustin A and erbstatin analogue also decreased PRL mRNA to a lesser extent than genistein and herbimycin A. RG-13022 had no effect. The inhibitory effects on PRL mRNA levels of lavendustin A and erbsatin analogue, and to a lesser extent genistein, were accompanied by a noticable decrease in cell viability, as Ž well as cell-cell and cell-matrix adhesion data not . shown . In contrast, herbimycin A strongly and reproducibly inhibited PRL gene expression, but had little or no effect on the expression of several other genes, including growth hormone. Also, in at least 10 100% from one representative experiment. Variation between duplicates was less than 5%, except for RG-13022 values, which varied by 20%.
( ) experiments, herbimycin A had no visible effect on cell viability or general appearance, calcium-induced cell-cell adhesion or adhesion of cells to the tissue Ž . culture dish data not shown . Therefore, herbimycin A was used exclusively for completion of this study.
In a representative experiment shown in Fig. 2A , treatment of GH cells with CaCl increased PRL by 3 2 Ž . in the absence SFM control or presence of 0.5 mM CaCl . 2 
Ž
. Herbimycin A 0.5 mgrml was then added for 2.5, 5 and 10 h. PRL mRNA was assayed in duplicate samples by Northern blot hybridization and quantified as described in Section 2. Data are presented as the means of values from duplicate cultures. There was less than 10% variation between duplicates. about 5-fold over SFM controls. Herbimycin A at a concentration of 0.5 mgrml completely blocked the effect of CaCl , reducing PRL mRNA levels to 14% 2 of the CaCl -induced levels. CaCl also induced a 2 2 Ž . small i.e., 1.5-to 2-fold increase in GH mRNA. Herbimycin A had no effect on these slightly ele-Ž . vated GH mRNA levels Fig. 1A . In four separate Ž . experiments each performed with duplicate cultures , Ž . herbimycin A significantly P -0.001 reduced PRL mRNA levels by 69 " 12%, but did not affect levels Ž of GAPDH mRNA or GRP78 mRNA data not . shown . Herbimycin A reduced both cytoplasmic PRL Ž . mRNA Fig. 2A and nuclear PRL gene transcripts Ž . Fig. 2B .
Previous studies with herbimycin A indicate that the drug acts by promoting the degradation of spew x cific PTKs 18 . In the experiment shown in Fig. 3 , we examined the relative rapidity of the effect of herbimycin A in GH cells that had been pretreated 3 overnight in SFM plus 0.5 mM CaCl . CaCl in- 2 2 creased PRL mRNA about 3-fold over SFM control. Consistent with previous studies which indicate a Ž . relatively slow effect of the drug 18 , herbimycin A had essentially no effect after 2.5 h, but depressed PRL mRNA levels by about 50% at 5 h and 10 h. 
Effects of herbimycin A on the tyrosine-specific phosphorylation of GH cell proteins and PRL gene 3 expression are reÕersible
The effects of herbimycin A on protein tyrosine phosphorylation were examined by Western blot analysis using an anti-phosphotyrosine antibody. In cells treated overnight with herbimycin A, PRL mRNA levels were undetectable and a low level of apparent phosphotyrosine staining was observed on Ž . Western blots Fig. 4A . This staining was nonspecific, as it was detected in the absence of primary Ž . antibody data not shown . Subsequent to changing the medium back to SFM containing 0.5 mM CaCl , 2 PRL mRNA levels slowly increased over a 24 h Ž . period Fig. 4A , upper panel . Concomitantly, an increased phosphotyrosine staining of two or more proteins in the range of approximately 130-160 kDa Ž . was detected Fig. 4A , lower panel . The phosphotyrosine staining of these proteins was not observed Ž . in the absence of primary antibody data not shown , nor was it detected in cells that were continually Ž . cultured in herbimycin A Fig. 4B or in herbimycin A-pretreated cells switched to SFM without CaCl2
Ž . for 24 h lane 1, Fig. 4A . 
Effects of herbimycin A on PRL expression and tyrosine phosphorylation in 235-1 lactotropes
The 235-1 cell line was independently derived w x from GH cells, and only produces PRL 19 . PRL . 235-1 cells compare Fig. 4 to Fig. 5 , in that one or more proteins in the molecular weight range of 130-160 kDa were strongly stained with anti-phospho-tyrosine antibody. Both tyrosine phosphorylation and the level of PRL mRNA in 235-1 cells were de-Ž . creased by herbimycin A treatment Fig. 5 .
Effects of herbimycin A on bFGF, EGF and TRH stimulation of PRL gene expression
The studies described above show that herbimycin A effectively inhibits the high basal level of PRL gene expression, as maintained by extracellular CaCl , in the absence of serum. PRL gene expression 2 is also regulated by numerous growth factors and hormones. We examined whether herbimycin A blocked three stimulators of PRL gene expression: bFGF, EGF and TRH. As shown in Fig. 6 , herbimycin A essentially completely blocked the effects of TRH and EGF, and inhibited the effects of FGF by about 60%.
We next examined whether the effects of herbimycin A could be reversed by bFGF after removal of the drug, similar to the experiment shown in Fig.  4 . Again, pretreatment with herbimycin A resulted in Ž loss of detection of both PRL mRNA Fig. 7, upper . Ž panel and tyrosine-specific phosphorylation Fig. 7 , . lower panel . Removal of the drug alone did not Ž . reverse these observations Fig. 7 ; lane 1 . However, addition of bFGF after removal of herbimycin A induced tyrosine phosphorylation by 6.5 h, and increased PRL mRNA by 12 h. The finding that both CaCl and bFGF required several hours to increase 2 tyrosine phosphorylation is consistent with previous reports that herbimycin A acts by inducing degrada- Fig. 6 . Herbimycin A inhibits the ability of TRH, EGF and FGF to increase PRL mRNA levels. Cells were treated essentially the same as Ž . Ž . Ž . described in Fig. 2 , except that cells were induced with either TRH 100 nM , EGF 40 ngrml or bFGF FGF; 40 ngrml plus or minus 0.5 mgrml of herbimycin A. Note that FGF was examined in a separate experiment, and is shown with its own SFM control. This was repeated twice with the same results. Fig. 7 . The effects of herbimycin A are reversible by bFGF. This experiment was performed essentially as described in Fig. 4 , except that cells were treated after herbimycin A with 40 ngrml Ž . of bFGF FGF . Note that, as indicated, shorter time points were used for Western blot analysis than those used for Northern blot analysis. w x tion of PTKs 18 . We note that in GH cells not 3 pretreated with herbimycin A, CaCl and bFGF in-2 duce changes in tyrosine phosphorylation patterns Žw x . within minutes 20 , and data not shown .
( )
Discussion
Herbimycin A is a benzoquinonoid ansamycin antibiotic that reverses the morphology of various cells Ž transformed by oncogenic PTKs e.g., Src, Yes, Fps, . Ros, Abl, Ret, and Erb B but not by oncogenes Ž which do not posssess PTK activity e.g., Myc, Raf w x. and Ras; 21,22 . Herbimycin A specifically reduces the PTK activity of these oncogene products and thereby lowers the extent of tyrosine phosphorylation w x of cellular proteins 22 . Herbimycin A also alters the w x differentiated phenotype of various cells 22 . In the human chronic myelogenous leukemia K562 cell line expressing a mutated c-Abl with enhanced PTK activity, herbimycin A induced erythroid differentiation concomitant with a reduced tyrosine phosphorylation w x of the c-Abl kinase 23 . Herbimycin A is also capable of triggering endoderm differentiation in embryonal carcinoma F9 cells, and terminal erythroid difw x ferentiation of erythroleukemic MEL cells 24 . Given the above findings, it is not surprising that herbimycin A modulates specific gene expression. The drug increased fibronectin mRNA levels in RSV-inw x fected rat kidney cells 25 , and inhibited c-myc expression in mouse lymphoblastoma L5178Y cells w x 26 .
In this study, we examined whether several PTK inhibitors could block the ability of CaCl to induce 2 PRL gene expression. Most of these inhibitors reduced PRL mRNA nonspecifically andror severly decreased cell viability. Thus, it is likely that these drugs inhibited one or more PTKs which are essential for cell viability. On the other hand, herbimycin A effectively inhibited the CaCl -induced increase in 2 the levels of cytoplasmic PRL mRNA and nuclear PRL pre-mRNAs. Importantly, this effect of herbimycin A was highly specific for PRL, and was observed in two independently-derived pituitary tumor cell lines. Herbimycin A had no effect on cell viability or adhesion, and was completely reversible.
Although herbimycin A has been shown to inhibit several PTKs, the specificity of its effects in GH 3 cells argues that, in this cell type, herbimycin A Ž . inhibits one or a few PTK s that are specifically linked to PRL gene expression. We detected the presence of one or more proteins in the range of 130-160 kDa whose tyrosine-specific phosphorylation is inhibited by herbimycin A. This effect of herbimycin A can be reversed by both CaCl and 2 bFGF in a manner that is closely correlated with the reprise of PRL gene expression. These data support the assumption that herbimycin A elicits its effects on PRL gene expression in GH cells through inhibition 3 Ž . of one or more PTK s . However, we have neither determined the identity of the phosphorylated pro-( ) teins, nor any role of these proteins in the regulation of PRL gene expresson.
The finding that the reversal of herbimycin A-induced effects took several hours is consistent with the drugs ability to induce selective degradation of some Ž w x. of its targets e.g., lck 18 . Also, the finding that either CaCl or bFGF was required for this reversal 2 indicates that these stimulators of PRL gene expression may also promote the synthesis of a specific PTK, possibly as part of their ability to induce or maintain a lactotropic phenotype. In this light, it is interesting to note that the expression of other PTK genes is stimulated over a period of 24-48 h upon hormonal or growth factor induction of differentia-Ž w x. tion in other cell types e.g. 27 . Also, it is worth noting that factors which acutely stimulate PRL gene Ž . expression e.g., FGF, EGF, NGF have also been shown to induce other features of the lactotrope Žw x phenotype over a peroid of several days 28-30 ; our . unpublished observations . Thus, one explanation for the ability of herbimycin A to block several stimulatory factors is that GH cells may express a PTK 3 which plays a role in the maintenance of PRL gene expression as part of the differentiated function of these cells. Such a PTK could be required for PRL gene expression, but not necessarily be a component of the signal transduction pathways of CaCl , FGF, 2 EGF and TRH.
